Drug prescription pattern for asthma among nigerian doctors in general practice: A cross-sectional survey.

Annals of Thoracic Medicine
Ademola E FawibeA J Fasae

Abstract

A wide range of medications are now available for the treatment of asthma and selection of the optimal treatment combination of agents is essential. This study was designed to evaluate a self-reported drug prescribing pattern for asthma among Nigerian doctors in general practice. It was a cross-sectional survey conducted among general practitioners in six states of Nigeria. For acute severe asthma, 75.9% of the doctors prescribed intravenous methylxanthines, which was combined with oral or inhaled short-acting β(2) agonists (SABA) by 56.3% of them. Systemic steroids were prescribed mainly via the intravenous route by 58.8% of them. Aberrant drugs such as antibiotics, antihistamines, and mucolytics were prescribed by 25.6% of them. For long-term, follow-up treatment of asthma, oral steroids, and oral SABA were commonly prescribed, while inhaled corticosteroids (ICS) and ICS/LABA (long acting beta agonists) were infrequently prescribed. Aberrant drugs such as analgesics, antimalaria, and antihistamines were prescribed by 22.8% of them. About 48% of the doctors had never attended any form of update training on asthma management, whereas, only 16.3% attended update training on asthma within the last year preceding this study. Aware...Continue Reading

References

Jun 1, 1990·Annals of Internal Medicine·C E Reed, L W Hunt
Aug 26, 1998·JAMA : the Journal of the American Medical Association·H A GansY Maldonado
May 27, 2003·The European Respiratory Journal·J M WraightD R Taylor
Jun 9, 2004·Respirology : Official Journal of the Asian Pacific Society of Respirology·Jonathan M WraightD Robin Taylor
Jun 21, 2005·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Kevin R Murphy
Oct 21, 2005·Chest·Michael SchatzThomas B Stibolt
Mar 7, 2009·The New England Journal of Medicine·Christopher H Fanta
Nov 3, 2009·Annals of Thoracic Medicine·Mohamed S Al-MoamaryMaha Al Dabbagh
Sep 8, 2010·The New England Journal of Medicine·Stephen C Lazarus
Jan 28, 2012·The European Respiratory Journal·Louis-Philippe BouletEric D Bateman

❮ Previous
Next ❯

Citations

Oct 12, 2013·Annals of Medical and Health Sciences Research·Cc OnyedumC Ezeudo
Feb 14, 2016·BMC Pulmonary Medicine·Emilia Jumbe MarsdenJulio Anchochea
Mar 4, 2015·Annals of the American Thoracic Society·Daniel ObasekiGregory Erhabor
Mar 31, 2015·International Journal of Immunopathology and Pharmacology·Abdolaziz Rastegar LariMorovat Taherikalani
Nov 7, 2019·Asthma Research and Practice·Pisirai NdarukwaElopy N Sibanda
Sep 29, 2020·Tropical Medicine & International Health : TM & IH·Obianuju B OzohDavid Beran

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The New England Journal of Medicine
George Rust
The New England Journal of Medicine
Miles Weinberger, Mutasim Abu-Hasan
© 2021 Meta ULC. All rights reserved